Name:
In Focus: cell cryopreservation and cold chain
Description:
In Focus: cell cryopreservation and cold chain
Thumbnail URL:
https://cadmoremediastorage.blob.core.windows.net/6ea13b66-273e-48f4-8660-a945b7f38089/thumbnails/6ea13b66-273e-48f4-8660-a945b7f38089.PNG
Duration:
T00H01M16S
Embed URL:
https://stream.cadmore.media/player/6ea13b66-273e-48f4-8660-a945b7f38089
Content URL:
https://cadmoreoriginalmedia.blob.core.windows.net/6ea13b66-273e-48f4-8660-a945b7f38089/Cryo Brooks V4.mp4?sv=2019-02-02&sr=c&sig=pa7GXk2N3j9aDPNRQLawN%2Be0l9IO5cRRFePuZQLu9N4%3D&st=2024-05-08T04%3A26%3A50Z&se=2024-05-08T06%3A31%3A50Z&sp=r
Upload Date:
2021-05-18T00:00:00.0000000
Transcript:
Language: EN.
Segment:0 .
[MUSIC PLAYING]
SPEAKER: Hello, and welcome to RegMedNet. This month, we're putting a focus on cell cryopreservation and cold chain. When thinking about the commercial and clinical development of cell therapies, cryopreservation and cold chain processes are essential elements to consider. Optimizing the cold chain process is absolutely crucial, as suboptimal cryopreservation can not only lead to batch-to-batch variation, but also a reduced cell yield and lowered cellular functionality.
SPEAKER: In this feature, we'll delve further into cold chain process control in advanced therapies. This includes how the new wave of advanced therapies is challenged by the cold chain requirements and the evolving distribution infrastructure. We will also be speaking to experts from Brooks Life Sciences to discuss the cryopreservation of advanced therapies, including the challenges of building a scalable solution from the discovery phases through to commercialization.
SPEAKER: We'll also explore how these challenges could be addressed and how cryopreservation protocols might evolve over the next 5 to 10 years from now. Join the conversation today at regmednet.com, or follow the discussion on Twitter, Facebook, and LinkedIn. We'll see you there. [MUSIC PLAYING]